Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Commercial weight loss programs have long been a popular option for those looking to shed a few pounds or manage their weight, but recently, they’ve evolved dramatically—parti ...

MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.

Q1 2025 Earnings Call Transcript April 28, 2025 Medifast, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, ...

Greetings, and welcome to the Medifast first quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over ...

Q1 2025 Management View CEO Dan Chard emphasized the company's focus on the evolving weight-loss market, highlighting the ...